EUVIMEDEUVIMED entdecken
Open Access

Postacute COVID-19 Symptoms and Health Care Utilization and Spending Among Traditional Medicare Beneficiaries

Kaushik Ghosh, Rachael Zuckerman, Yevgeniy Feyman, E John Orav, Steven Sheingold

JAMA Network Open · 06.07.2026 · 9 (7) · e2621731

DOI: 10.1001/jamanetworkopen.2026.21731 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 06.07.2026. Verfasst von Kaushik Ghosh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Office of Health Policy, Assistant Secretary for Planning and Evaluation, US Department of Health and Human Services, Washington, DC. Hauptthemen laut MEDLINE: COVID-19, Medicare, Patient Acceptance of Health Care, Health Expenditures. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Postacute sequelae of SARS-CoV-2 infection include fatigue, respiratory symptoms, and cognitive dysfunction. However, the extent to which these symptoms contribute to increased health care utilization and spending among Medicare beneficiaries remains unclear.

Objective

To quantify differences in postacute symptoms and health care utilization and spending between traditional Medicare beneficiaries with COVID-19 and matched control beneficiaries without COVID-19. Design, Setting, and Participants This cohort study used traditional Medicare claims from February 2020 through November 2022. Beneficiaries with a documented COVID-19 diagnosis were matched 1:5 to beneficiaries without COVID-19 based on demographic and clinical characteristics. Four variant-defined cohorts (original strain and Alpha, Delta, and Omicron variants) were analyzed. Follow-up extended through 40 weeks after diagnosis. Data were analyzed from February 2020 to November 2022. Main Outcomes and Measures Diagnosis of 21 postacute COVID-19 symptoms, all-cause health care utilization, and Medicare spending were compared between those with COVID-19 and matched control beneficiaries using logistic and linear regression models adjusted for demographic and clinical covariates.

Results

The cohort study included 937 077 Medicare beneficiaries with COVID-19 and 4 808 573 matched control beneficiaries without COVID-19 (3 109 789 females [54.1%]), with most beneficiaries (4 880 497 [84.9%]) aged 65 years or older. During the acute phase of infection (diagnosis week), beneficiaries with COVID-19 were 41.71 (95% CI, 41.62-41.91) percentage points more likely to receive at least 1 postacute symptom diagnosis than control beneficiaries. This difference declined to 5.22 (95% CI, 5.11-5.32) percentage points during weeks 1 to 12 and to 1.94 (95% CI, 1.81-2.05) percentage points during weeks 13 to 40. Medicare spending was $7933.13 higher (95% CI, $7904.12-$7962.14) in the acute phase, decreasing to $232.31 (95% CI, $230.11-$234.14) per week in weeks 1 to 12 and to $28.21 (95% CI, $27.11-$30.13) per week in weeks 13 to 40. Differences in health care utilization followed a similar pattern, decreasing to 0.05 (95% CI, 0.05-0.06) visits per week in weeks 1 to 12 and to 0.03 (95% CI, 0.02-0.03) visits per week in weeks 13 to 40. Conclusions and Relevance In this cohort study of traditional Medicare beneficiaries across major COVID-19 variants, postacute symptom diagnoses and health care utilization and spending were substantially higher in the acute phase of COVID-19 but diminished over time, approaching levels observed in matched control beneficiaries without COVID-19 by 3 months after infection. These findings suggest limited long-term excess health care utilization or spending attributable to COVID-19 infection among older adults.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19MedicarePatient Acceptance of Health CareHealth ExpendituresHumansUnited StatesFemaleMaleAgedAged, 80 and overPost-Acute COVID-19 SyndromeSARS-CoV-2Cohort Studies

Autor:innen und Institutionen

  • Office of Health Policy, Assistant Secretary for Planning and Evaluation, US Department of Health and Human Services, Washington, DC.
  • Research and Analytics, American Medical Group Association, Alexandria, Virginia.
  • Department of Pharmacy, University of Washington, Seattle.
  • Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Zitieren

APA

Ghosh, K., Zuckerman, R., Feyman, Y., Orav, E. J., & Sheingold, S. (2026). Postacute COVID-19 Symptoms and Health Care Utilization and Spending Among Traditional Medicare Beneficiaries. JAMA Network Open, 9(7), e2621731. https://doi.org/10.1001/jamanetworkopen.2026.21731

Vancouver

Ghosh K, Zuckerman R, Feyman Y, Orav EJ, Sheingold S. Postacute COVID-19 Symptoms and Health Care Utilization and Spending Among Traditional Medicare Beneficiaries. JAMA Network Open. 2026;9(7):e2621731. doi:10.1001/jamanetworkopen.2026.21731

BibTeX
@article{Ghosh2026,
  author = {Ghosh, Kaushik and Zuckerman, Rachael and Feyman, Yevgeniy and Orav, E John and Sheingold, Steven},
  title = {Postacute COVID-19 Symptoms and Health Care Utilization and Spending Among Traditional Medicare Beneficiaries},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {7},
  pages = {e2621731},
  doi = {10.1001/jamanetworkopen.2026.21731}
}
Kostenlos starten →